IL-10 serum levels are higher in patients with DHF/DSS [25]–[31], and furthermore, ADE-enhanced IL-10/SOCS3 expression may interfere with the antiviral response to IFN [20], . This evidence concerns the gene IFNA1 and acute disseminated encephalomyelitis.